3 completed, 2 unknown, 1 active not recruiting, 1 withdrawn. 3 Phase 1, 2 Phase 2, 2 Phase 4, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Unknown 1 |
| Phase 2 | 2 | Active not recruiting 1, Unknown 1 |
| Phase 4 | 2 | Unknown 1, Withdrawn 1 |
| Not applicable | 1 | Completed 1 |
Follow Drug and Narcotic Control: new trials by email Literature Review of Drug and Narcotic Control trials Research Report on Drug and Narcotic Control
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Therapeutic Effects of Bu Shen Yi Jing Pill on Semen Quality in Sub Fertile Males: a Randomized Controlled Trial Bu Shen Yi Jing Pill, Placebo Drug - Male Infertility, Infertility | Phase 2 | Active not recruiting | KK Women's and Children's Hospital | 59 | 2022-01-07 | 2024-10-10 |
| The Effect of Omega-3 FA on Glucose and Lipid Homeostasis Disorders in Obese/Diabetic Patients Low dose omega-3 fatty acid supplementation, High dose omega-3 fatty acid supplementation, Control drug - Hyperglycaemia (Diabetic), Hyperlipidemias | Not applicable | Completed | Zhejiang University | 415 | 2020-10-10 | 2024-07-12 |
| Study to Assess Safety and Efficacy of Kabiven® in Pediatric Patients 2 to 16 Years of Age Kabiven®, Compounded standard parenteral nutrition - Malnutrition | Phase 4 | Withdrawn | Fresenius Kabi | 2018-03-01 | 2019-09-04 | |
| Study of Hepalatide(L47) at Phase Ib in Healthy Volunteers Hepalatide, Placebo - Hepatitis B， Chronic | Phase 1 | Completed | Shanghai HEP Pharmaceutical Co., Ltd. | 35 | 2016-08-01 | 2017-01-23 |
| Early Goal Directed Sedation on Microcirculation in Septic Shock Dexmedetomidine for sedation - Septic Shock | Phase 4 | Unknown | Southeast University, China | 25 | 2015-11-01 | 2016-04-20 |
| Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy Volunteers Hepalatide, Placebo - Hepatitis B， Chronic | Phase 1 | Completed | Shanghai HEP Pharmaceutical Co., Ltd. | 48 | 2015-10-01 | 2017-02-14 |
| The Treatment With HBIG+GM-CSF+HBV Vaccine for Chronic Hepatitis B Patients With HBeAg Seroconversion Drug, GM-CSF control - Chronic Hepatitis B | Phase 1 / Phase 2 | Unknown | Beijing 302 Hospital | 40 | 2013-06-01 | 2013-07-24 |
Hepatitis B, Chronic (3) · Diabetes Mellitus, Type 2 (1) · Hyperglycemia (1) · Hyperlipidemias (1) · Hyperphagia (1) · Infertility (1) · Infertility, Male (1) · Malnutrition (1) · Obesity (1) · Shock, Septic (1)
Shanghai HEP Pharmaceutical Co., Ltd. (2) · Beijing 302 Hospital (1) · Fresenius Kabi (1) · KK Women's and Children's Hospital (1) · Southeast University, China (1) · Zhejiang University (1)
China (5) · Singapore (1) · United States (1)
Fu-Sheng Wang, M.D. (1) · Joel D Lim, MD (1) · Tat Xin Ee, MD (1) · Yi Yang, Ph.D. (1)